Adagene Inc. - ADS, each representing 1.25 ordinary shares (ADAG) analyst actions
Rating and price-target actions on ADAG in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ADAG overview →
1 measured ADAG analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer | Press release | +7.25% | +1.50% |
Keep exploring
More ADAG: earnings → · SEC filings → · ADAG overview →